🇧🇷 Catapres-Tts-1 in Brazil

Catapres-Tts-1 (CLONIDINE) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Catapres-Tts-1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Brazil

Frequently asked questions

Is Catapres-Tts-1 approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Catapres-Tts-1 in Brazil?

Lavipharm is the originator. The local marketing authorisation holder may differ — check the official source linked above.